These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067 [TBL] [Abstract][Full Text] [Related]
66. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis. Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032 [TBL] [Abstract][Full Text] [Related]
67. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891 [TBL] [Abstract][Full Text] [Related]
68. p16INK4a as a second effector of the telomere damage pathway. Jacobs JJ; de Lange T Cell Cycle; 2005 Oct; 4(10):1364-8. PubMed ID: 16177573 [TBL] [Abstract][Full Text] [Related]
69. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081 [TBL] [Abstract][Full Text] [Related]
70. [What do we know about ATM protein expression in breast tissue?]. Angèle S; Tanière P; Hall J Bull Cancer; 2001 Jul; 88(7):671-5. PubMed ID: 11495820 [TBL] [Abstract][Full Text] [Related]
71. Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Wei G; DeFeo K; Hayes CS; Woster PM; Mandik-Nayak L; Gilmour SK Cancer Res; 2008 Apr; 68(7):2214-22. PubMed ID: 18381427 [TBL] [Abstract][Full Text] [Related]
72. No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells. Erdmann N; Harrington LA DNA Repair (Amst); 2009 Mar; 8(3):347-53. PubMed ID: 19071232 [TBL] [Abstract][Full Text] [Related]
73. Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas. Begemann S; Galimi F; Karlseder J Aging (Albany NY); 2009 Jan; 1(1):122-130. PubMed ID: 20046894 [TBL] [Abstract][Full Text] [Related]
74. Elevated TRF2 in advanced breast cancers with short telomeres. Diehl MC; Idowu MO; Kimmelshue KN; York TP; Jackson-Cook CK; Turner KC; Holt SE; Elmore LW Breast Cancer Res Treat; 2011 Jun; 127(3):623-30. PubMed ID: 20625812 [TBL] [Abstract][Full Text] [Related]
75. Cutaneous squamous cell carcinoma (SCC) and the DNA damage response: pATM expression patterns in pre-malignant and malignant keratinocyte skin lesions. Ismail F; Ikram M; Purdie K; Harwood C; Leigh I; Storey A PLoS One; 2011; 6(7):e21271. PubMed ID: 21747934 [TBL] [Abstract][Full Text] [Related]
77. The telomere deprotection response is functionally distinct from the genomic DNA damage response. Cesare AJ; Hayashi MT; Crabbe L; Karlseder J Mol Cell; 2013 Jul; 51(2):141-55. PubMed ID: 23850488 [TBL] [Abstract][Full Text] [Related]
78. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873 [TBL] [Abstract][Full Text] [Related]
79. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Li Y; Pan J; Li JL; Lee JH; Tunkey C; Saraf K; Garbe JC; Whitley MZ; Jelinsky SA; Stampfer MR; Haney SA Mol Cancer; 2007 Jan; 6():7. PubMed ID: 17233903 [TBL] [Abstract][Full Text] [Related]
80. Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Lazzerini Denchi E; Celli G; de Lange T Genes Dev; 2006 Oct; 20(19):2648-53. PubMed ID: 17015429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]